Celgene
Celgene Corporation is a pharmaceutical company based in Summit, New Jersey, U.S. Its main product is Thalomid, used to treat bone marrow cancer as well as a form of leprosy. (Thalomid is a form of the infamous thalidomide sedative which was used in the 1950s until it was realized that it caused birth defects.) Another of Celgene's drugs is Revlimid which is used to treat the malignant blood disease MDS. [1]
In 2006, sales were nearly US$900 million with profits of US$69 million. [1]
Contents
Lobbying
Celgene spent $160,000 for lobbying in 2006. All of the money went to the lobbying firms - The Washington Group and Sidley Austin. [2]
Personnel
Key executives and 2006 pay: [3]
- Sol J. Barer, Chairman and Chief Executive Officer, $16,084,329 (also exercised $33,719,410 in options)[4]
- Robert J. Hugin, Chief Operating Officer, $7,777,660[5]
- David W. Gryska, Chief Financial Officer, $263,730[6]
- Aart Brouwer, Divisional President, $835,247[7]
Selected members of the Board of Directors: [8]
- Rodman L. Drake, Also Director of Jackson Hewitt and Student Loan Corporation (Sallie Mae)
- Arthur Hull Hayes, Jr., Former Commissioner of the U.S. Food and Drug Administration under Ronald Reagan
- Gilla Kaplan, Professor
Contact details
86 Morris Avenue
Summit, NJ 07901
Phone: 908-673-9000
Fax: 908-673-9001
Web: http://www.celgene.com
Articles & sources
Related SourceWatch articles
References
- ↑ Jump up to: 1.0 1.1 Celgene Profile, Hoovers, accessed January 2008.
- ↑ Celgene lobbying expenses, Open Secrets, accessed January 2008.
- ↑ Corporate Governance - Management, Celgene, accessed January 2008.
- ↑ Sol J Barer, Forbes, accessed January 2008.
- ↑ Robert J Hugin, Forbes, accessed January 2008.
- ↑ David W Gryska, Forbes, accessed January 2008.
- ↑ Aart Brouwer, Forbes, accessed January 2008.
- ↑ Board of Directors, Celgene, accessed January 2008.
